Curcumin for Renal Transplant Health
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment who have few treatment options. The possible mechanisms by which curcumin improves vascular function will be evaluated as well as whether curcumin improves cognitive function in these patients.
Who Is on the Research Team?
Pierpaolo Di Cocco, MD, PhD
Principal Investigator
University of Illinois at Chicago
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have received a kidney transplant from either a living or deceased donor. It's not open to those who've had multiple organ transplants or were taking curcumin before their kidney transplant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either curcumin or placebo starting at the time of transplant or up to 2 weeks prior, with follow-up visits at 0, 3, 6, and 12 months post-transplant
Follow-up
Participants are monitored for safety and effectiveness after treatment, with additional blood and urine samples collected for future analysis
What Are the Treatments Tested in This Trial?
Interventions
- Curcumin
Curcumin is already approved in United States, European Union, India, China for the following indications:
- Dietary Supplement
- Herbal Medicinal Product
- Traditional Medicine
- Traditional Chinese Medicine
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Verdure Sciences
Industry Sponsor